MA41985B1 - Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux - Google Patents
Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinauxInfo
- Publication number
- MA41985B1 MA41985B1 MA41985A MA41985A MA41985B1 MA 41985 B1 MA41985 B1 MA 41985B1 MA 41985 A MA41985 A MA 41985A MA 41985 A MA41985 A MA 41985A MA 41985 B1 MA41985 B1 MA 41985B1
- Authority
- MA
- Morocco
- Prior art keywords
- gastrointestinal disorders
- cleansing
- colon
- composition
- treating gastrointestinal
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000001072 colon Anatomy 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562156077P | 2015-05-01 | 2015-05-01 | |
| PCT/US2016/030061 WO2016178979A1 (en) | 2015-05-01 | 2016-04-29 | Compositions for colon cleansing and the treatment of gastrointestinal disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA41985A MA41985A (fr) | 2018-03-07 |
| MA41985B1 true MA41985B1 (fr) | 2023-04-28 |
Family
ID=55953439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA41985A MA41985B1 (fr) | 2015-05-01 | 2016-04-29 | Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10618938B2 (enExample) |
| EP (2) | EP4218789A3 (enExample) |
| JP (5) | JP6930919B2 (enExample) |
| KR (2) | KR102783759B1 (enExample) |
| CN (2) | CN114716514A (enExample) |
| CA (2) | CA2984437C (enExample) |
| CY (1) | CY1126031T1 (enExample) |
| DK (1) | DK3288578T5 (enExample) |
| EA (1) | EA201792401A1 (enExample) |
| ES (1) | ES2947591T3 (enExample) |
| FI (1) | FI3288578T3 (enExample) |
| HR (1) | HRP20230381T1 (enExample) |
| HU (1) | HUE061954T2 (enExample) |
| LT (1) | LT3288578T (enExample) |
| MA (1) | MA41985B1 (enExample) |
| MD (1) | MD3288578T2 (enExample) |
| MX (2) | MX2017013928A (enExample) |
| PL (1) | PL3288578T3 (enExample) |
| PT (1) | PT3288578T (enExample) |
| RS (1) | RS64160B1 (enExample) |
| SI (1) | SI3288578T1 (enExample) |
| SM (1) | SMT202300114T1 (enExample) |
| WO (1) | WO2016178979A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102783759B1 (ko) * | 2015-05-01 | 2025-03-21 | 아이언우드 파마슈티컬스, 인코포레이티드 | 결장 세정을 위한 조성물 및 위장 장애의 치료 |
| SMT202200173T1 (it) | 2016-06-01 | 2022-05-12 | Athira Pharma Inc | Composti |
| EP4436980A1 (en) * | 2021-11-24 | 2024-10-02 | Ironwood Pharmaceuticals, Inc. | Synthetic process for production of modified gcc receptor agonists |
| MX2024006317A (es) * | 2021-11-24 | 2024-06-19 | Ironwood Pharmaceuticals Inc | Proceso sintetico para la produccion de agonistas del receptor de guanilato ciclasa c (gcc) modificados. |
| EP4440595A1 (en) * | 2021-11-29 | 2024-10-09 | Ironwood Pharmaceuticals, Inc. | Pharmaceutical compositions for the treatment of visceral pain |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689139A5 (de) | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung. |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| DE602004028678D1 (de) * | 2003-01-28 | 2010-09-23 | Ironwood Pharmaceuticals Inc | Zusammensetzungen zur Behandlung von Magen-Darm-Störungen |
| US7494979B2 (en) * | 2003-06-13 | 2009-02-24 | Ironwood Pharmaceuticals, Inc. | Method for treating congestive heart failure and other disorders |
| CA2619650A1 (en) * | 2005-08-19 | 2007-02-22 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP2331561A4 (en) * | 2008-09-03 | 2013-02-27 | Xenome Ltd | PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME |
| WO2011103311A2 (en) * | 2010-02-17 | 2011-08-25 | Ironwood Pharmaceuticals, Inc | Treatments for gastrointestinal disorders |
| KR102034748B1 (ko) * | 2011-03-01 | 2019-10-21 | 시너지 파마슈티컬즈 인코포레이티드 | 구아닐레이트 사이클라제 c 작용제의 제조 방법 |
| EP3718557A3 (en) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing |
| EP4424697A3 (en) * | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| WO2016015055A1 (en) * | 2014-07-25 | 2016-01-28 | Ironwood Pharmaceuticals, Inc. | Colon cleansing compositions |
| KR102783759B1 (ko) * | 2015-05-01 | 2025-03-21 | 아이언우드 파마슈티컬스, 인코포레이티드 | 결장 세정을 위한 조성물 및 위장 장애의 치료 |
-
2016
- 2016-04-29 KR KR1020177034808A patent/KR102783759B1/ko active Active
- 2016-04-29 MD MDE20180232T patent/MD3288578T2/ro unknown
- 2016-04-29 MA MA41985A patent/MA41985B1/fr unknown
- 2016-04-29 PT PT167216092T patent/PT3288578T/pt unknown
- 2016-04-29 HR HRP20230381TT patent/HRP20230381T1/hr unknown
- 2016-04-29 HU HUE16721609A patent/HUE061954T2/hu unknown
- 2016-04-29 SM SM20230114T patent/SMT202300114T1/it unknown
- 2016-04-29 CA CA2984437A patent/CA2984437C/en active Active
- 2016-04-29 LT LTEPPCT/US2016/030061T patent/LT3288578T/lt unknown
- 2016-04-29 EP EP23159398.9A patent/EP4218789A3/en active Pending
- 2016-04-29 CN CN202210288669.XA patent/CN114716514A/zh active Pending
- 2016-04-29 EA EA201792401A patent/EA201792401A1/ru unknown
- 2016-04-29 PL PL16721609.2T patent/PL3288578T3/pl unknown
- 2016-04-29 MX MX2017013928A patent/MX2017013928A/es unknown
- 2016-04-29 CA CA3172777A patent/CA3172777A1/en active Pending
- 2016-04-29 US US15/570,838 patent/US10618938B2/en active Active
- 2016-04-29 RS RS20230311A patent/RS64160B1/sr unknown
- 2016-04-29 JP JP2017557067A patent/JP6930919B2/ja active Active
- 2016-04-29 DK DK16721609.2T patent/DK3288578T5/da active
- 2016-04-29 ES ES16721609T patent/ES2947591T3/es active Active
- 2016-04-29 WO PCT/US2016/030061 patent/WO2016178979A1/en not_active Ceased
- 2016-04-29 EP EP16721609.2A patent/EP3288578B8/en active Active
- 2016-04-29 KR KR1020257008457A patent/KR20250042844A/ko active Pending
- 2016-04-29 CN CN201680032088.2A patent/CN108040482B/zh active Active
- 2016-04-29 SI SI201631712T patent/SI3288578T1/sl unknown
- 2016-04-29 FI FIEP16721609.2T patent/FI3288578T3/fi active
-
2017
- 2017-10-30 MX MX2022013283A patent/MX2022013283A/es unknown
-
2020
- 2020-09-30 JP JP2020165328A patent/JP2020203954A/ja not_active Withdrawn
-
2022
- 2022-07-04 JP JP2022107644A patent/JP2022121734A/ja active Pending
-
2023
- 2023-05-26 CY CY20231100253T patent/CY1126031T1/el unknown
- 2023-12-11 JP JP2023208395A patent/JP2024015335A/ja active Pending
-
2024
- 2024-01-26 US US18/424,114 patent/US20240199697A1/en active Pending
-
2025
- 2025-08-12 JP JP2025134346A patent/JP2025169325A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024008539A (es) | Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma. | |
| EA201290322A1 (ru) | Лечение желудочно-кишечных расстройств | |
| EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| EA201170036A1 (ru) | Соединения боронатного эфира и его фармацевтические составы | |
| EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
| EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
| MA41985B1 (fr) | Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux | |
| EA201691242A1 (ru) | Фармацевтические композиции, содержащие azd9291 | |
| EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
| EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
| ATE530540T1 (de) | Pyrimidonverbindungen als gsk-3-inhibitoren | |
| EA201071291A3 (ru) | Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| EA201790653A1 (ru) | Способ лечения болезни альцгеймера и других расстройств | |
| MA44426B1 (fr) | Compositions et méthodes pour diminier l'expression de tau | |
| EA201290860A1 (ru) | Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата | |
| MX2022000712A (es) | Moduladores de nlrp3. | |
| MA38253B1 (fr) | Compositions comprenant de la vortioxétine et du donépézil | |
| ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| EA201171035A1 (ru) | Композиции, включающие модуляторы pde4, и способ их применения для лечения, профилактики и сопровождения туберкулеза | |
| EA202190057A1 (ru) | Солюбилизированные апиразы, способы и применение | |
| BRPI0907220A2 (pt) | métodos de tratar distúrbios de perda óssea usando um antagonista de gm-csf |